| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $179M | — | $180M | — | -0.4% |
| Op. Income | $9M | — | $10M | — | -14.8% |
| Gross Margin | 10.2% | — | 11.2% | — | -1.0pp |
| Net Margin | 2.6% | — | -0.4% | — | 3.0pp |
| EPS (Diluted) | $0.49 | — | $-0.04 | — | 1295.1% |
| Free Cash Flow | $7M | — | $11M | — | -35.2% |
| Item | Amount |
|---|---|
| REVENUE | $179M |
| Cost of Revenue | $161M |
| GROSS PROFIT | $18M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $9M |
| Other Expenses | $307.0K |
| Operating Expenses | $10M |
| Cost & Expenses | $170M |
| OPERATING INCOME | $9M |
| Interest Income | $879.0K |
| Interest Expense | $199.0K |
| Other Income/Expenses | -$2M |
| INCOME BEFORE TAX | $7M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $5M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $5M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $5M |
| D&A | $2M |
| EBIT | $7M |
| EBITDA | $9M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $179M |
| Cost of Revenue | $161M |
| GROSS PROFIT | $18M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $9M |
| Other Expenses | $307.0K |
| Operating Expenses | $10M |
| Cost & Expenses | $170M |
| OPERATING INCOME | $9M |
| Interest Income | $879.0K |
| Interest Expense | $199.0K |
| Other Income/Expenses | -$2M |
| INCOME BEFORE TAX | $7M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $5M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $5M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $5M |
| D&A | $2M |
| EBIT | $7M |
| EBITDA | $9M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $5M |
| Depreciation & Amortization | $2M |
| Stock-Based Compensation | $283.0K |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$509.0K |
| Change in Working Capital | $2M |
| OPERATING CASH FLOW | $8M |
| Capital Expenditure | -$651.0K |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$651.0K |
| Net Debt Issuance | -$348.0K |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$4M |
| Other Financing Activities | -$2.0K |
| NET CASH FROM FINANCING | -$4M |
| FREE CASH FLOW | $7M |
| Net Change in Cash | $3M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $64M |
| Short-Term Investments | $0 |
| Net Receivables | $42M |
| Inventory | $30M |
| Other Current Assets | $8M |
| TOTAL CURRENT ASSETS | $159M |
| PP&E (Net) | $67M |
| Goodwill | $10M |
| Intangible Assets | $0 |
| Long-Term Investments | $3M |
| Tax Assets | $7M |
| Other Non-Current Assets | $54M |
| TOTAL NON-CURRENT ASSETS | $142M |
| TOTAL ASSETS | $301M |
| Account Payables | $42M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $11M |
| TOTAL CURRENT LIABILITIES | $69M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $4M |
| TOTAL NON-CURRENT LIABILITIES | $24M |
| TOTAL LIABILITIES | $93M |
| Common Stock | $18.0K |
| Additional Paid-In Capital | $179M |
| Retained Earnings | $28M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $206M |
| Minority Interest | $2M |
| TOTAL EQUITY | $208M |
| TOTAL LIABILITIES & EQUITY | $301M |
| Total Debt | $24M |
| Net Debt | -$40M |